China Health Group Inc. provided consolidated earnings guidance for the year ended 31 December 2017. The board of directors of the company inform shareholders and potential investors of the company that, according to the preliminary review of the unaudited consolidated management accounts of the group and other information currently available to the company, it is expected that the annual profit attributable to equity shareholders of the company for the year ended 31 December 2017 will increase significantly by more than 13 times as compared with the year of 2016. The expected significant increase was mainly due to the increase in the revenue, gross profit margin and net profit margin recognized in the year of 2017.